Landscapes / Companies
I-Mab Biopharma US Limited not checked
FollowEvery new trial, moved date and filing, and a Monday email
Drugs
1
in active trials · 5 in all
Trials
2 active
8 since 2021
Drugs1
| Drug | How it works | Partner | Stage
Sources: FDA: the drug development process, ClinicalTrials.gov glossary | Next date
| Details |
|---|---|---|---|---|---|
Multi-specific immunoglobulin |
Phase 2 | Mar 2030Phase 2 trial completes | |||
| How it works | An antibody built to latch onto two or more targets at once | ||||
| Next date | Mar 2030 · Phase 2 trial completes | ||||
| Also tested for | Solid Tumor, Advanced Cancer and 6 more | ||||
| Open drug page | |||||
About
- No active trial
- Plonmarlimab, TJ011133, TJ210001, Uliledlimab
- SEC filings
- None: it does not file with the US SEC
- Sources
- ClinicalTrials.gov updated 19 Nov 2026 Industry-sponsored drug trials since 2021